Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John P Moore

Showing results (201-210 of 320) with videos related to

Pageof 32
Sort By:
Journal of Virology|December 3, 2003
Macrophage-tropic simian/human immunodeficiency virus chimeras use CXCR4, not CCR5, for infections of rhesus macaque peripheral blood mononuclear cells and alveolar macrophagesTatsuhiko Igarashi, Olivia K Donau, Hiromi Imamichi, et al.
Nature|November 1, 2005
Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusionRonald S Veazey, Per Johan Klasse, Susan M Schader, et al.
Science (New York, N.Y.)|November 2, 2013
Crystal structure of a soluble cleaved HIV-1 envelope trimerJean-Philippe Julien, Albert Cupo, Devin Sok, et al.
Nature|July 13, 2017
Open and closed structures reveal allostery and pliability in the HIV-1 envelope spikeGabriel Ozorowski, Jesper Pallesen, Natalia de Val, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 22, 2011
Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibodyDennis R Burton, Ann J Hessell, Brandon F Keele, et al.
Journal of Virology|March 30, 2004
The differential sensitivity of human and rhesus macaque CCR5 to small-molecule inhibitors of human immunodeficiency virus type 1 entry is explained by a single amino acid difference and suggests a mechanism of action for these inhibitorsErika Billick, Christoph Seibert, Pavel Pugach, et al.
Science (New York, N.Y.)|November 2, 2013
Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimerDmitry Lyumkis, Jean-Philippe Julien, Natalia de Val, et al.
Plos One|August 10, 2017
HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimersSilvia Capucci, Edmund G Wee, Torben Schiffner, et al.
Plos One|October 12, 2023
Correction: HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimersSilvia Capucci, Edmund G Wee, Torben Schiffner, et al.
AIDS Research and Human Retroviruses|June 27, 2006
Construction and characterization of soluble, cleaved, and stabilized trimeric Env proteins based on HIV type 1 Env subtype ASimon Beddows, Marc Kirschner, Lila Campbell-Gardener, et al.
Pageof 32

Showing results (201-210 of 320) with videos related to

Sort By:
Pageof 32
Journal of Virology|December 3, 2003
Macrophage-tropic simian/human immunodeficiency virus chimeras use CXCR4, not CCR5, for infections of rhesus macaque peripheral blood mononuclear cells and alveolar macrophagesTatsuhiko Igarashi, Olivia K Donau, Hiromi Imamichi, et al.
Nature|November 1, 2005
Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusionRonald S Veazey, Per Johan Klasse, Susan M Schader, et al.
Science (New York, N.Y.)|November 2, 2013
Crystal structure of a soluble cleaved HIV-1 envelope trimerJean-Philippe Julien, Albert Cupo, Devin Sok, et al.
Nature|July 13, 2017
Open and closed structures reveal allostery and pliability in the HIV-1 envelope spikeGabriel Ozorowski, Jesper Pallesen, Natalia de Val, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 22, 2011
Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibodyDennis R Burton, Ann J Hessell, Brandon F Keele, et al.
Journal of Virology|March 30, 2004
The differential sensitivity of human and rhesus macaque CCR5 to small-molecule inhibitors of human immunodeficiency virus type 1 entry is explained by a single amino acid difference and suggests a mechanism of action for these inhibitorsErika Billick, Christoph Seibert, Pavel Pugach, et al.
Science (New York, N.Y.)|November 2, 2013
Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimerDmitry Lyumkis, Jean-Philippe Julien, Natalia de Val, et al.
Plos One|August 10, 2017
HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimersSilvia Capucci, Edmund G Wee, Torben Schiffner, et al.
Plos One|October 12, 2023
Correction: HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimersSilvia Capucci, Edmund G Wee, Torben Schiffner, et al.
AIDS Research and Human Retroviruses|June 27, 2006
Construction and characterization of soluble, cleaved, and stabilized trimeric Env proteins based on HIV type 1 Env subtype ASimon Beddows, Marc Kirschner, Lila Campbell-Gardener, et al.
Pageof 32